Xavier PELFORT, Alba ROMERO, Montserrat BRUGUES, Amparo GARCİA, Sergi GİL, Anna MARRON

Reduction of periprosthetic Staphylococcus aureus infection by preoperative screening and decolonization of nasal carriers undergoing total knee arthroplasty

Objective: The aim of this study was to evaluate whether the establishment of a preoperative screening and decolonization protocol for Staphylococcus aureus carriers undergoing total knee arthroplasty (TKA) could decrease the incidence of periprosthetic joint infection (PJI) caused by this microorganism. Methods: We conducted a retrospective study comparing a control group comprising 400 patients (134 men, and 266 women; mean age: 72.2 ± 6.8 years) who went through surgery between January 2009 and December 2013, with a second intervention group of 403 patients (125 men, and 278 women; mean age: 72.4 ± 6.9 years) in which the protocol of screening and decolonization of S. aureus nasal carriers was applied between January 2014 and December 2016. During this latter period patients were preoperatively screened and, if positive, treated with mupirocin nasal ointment and chlorhexidine soap, for 5 days prior to surgery. Results: In the control group, 17 of 400 patients (4.2%) had a SSI, 8 (2%) of them caused by S. aureus and 9 (2.2%) by other microorganisms. In the intervention group 20.6% of patients had a positive S. aureus nasal swab and were treated according to the protocol. 5 of 403 patients (1.2%) in this group had a SSI, 1 (0.2%) due to S. aureus and 4 (1%) to other microorganisms. When comparing surgical-site infection (SSI) rates between the two groups, we found a statistically significant reduction in both global SSI (p ¼ 0.009) and specifically S. aureus SSI (p ¼ 0.02), in the intervention group. No decolonized S. aureus nasal carrier presented a SSI. Discussion: In patients undergoing TKA a preoperative screening and decolonization protocol for S. aureus nasal carriers, using mupirocin nasal ointment and chlorhexidine soap, is an effective measure to reduce the rate of SSI caused by this microorganism.

___

1. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780e781.

2. Kurtz S, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012;27:61e62.

3. Sousa RJ, Barreira PM, Leite PT, Santos AM, Ramos MH, Oliveira AF. Preoperative Staphylococcus aureus screening/decolonization protocol before total joint arthroplasty - results of a small prospective randomized trial. J Arthroplasty. 2016;31:234e239.

4. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. New Engl J Med. 2010;362:9e17.

5. Weiser MC, Moucha CS. The current state of screening and decolonization for the prevention of Staphylococcus aureus surgical site infection after total hip and knee arthroplasty. J Bone Joint Surg Am. 2015;97:1449e1458.

6. Chen AF, Heyl AE, Xu PZ, Rao N, Klatt BA. Preoperative decolonization effective at reducing Staphylococcal colonization in total joint arthroplasty patients. J Arthroplasty. 2013;28:18e20.

7. Slover J, Hass JP, Quirno M, Phillips MS, Bosco JA. Cost-effectiveness of a Staphylococcus aureus screening and decolonization program for high-risk orthopaedic patients. J Arthroplasty. 2011;26:360e365.

8. Stambough JB, Nam D, Warren DK, et al. Decreased hospital costs and surgical site infection incidence with a universal decolonization protocol in primary total joint arthroplasty. J Arthroplasty. 2017;32:728e734.

9. Courville XF, Tomek IM, Kirkland KB, Birhle M, Kantor SR, Finlayson SR. Costeffectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a costeffectiveness analysis. Infect Control Hosp Epidemiol. 2012;33:152e159.

10. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopaedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo controlled study. Clin Infect Dis. 2002;35: 353e358.

11. Hadley S, Immerman I, Hutzler L, Slover J, Bosco J. Staphylococcus aureus decolonization protocol decreases surgical site infections for total joint replacement. Arthritis. 2010;ID924518:1e4.

12. Schweizer M, Perencevich E, McDanel J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopaedic surgery: systematic review and meta-analysis. BMJ. 2013;346:1e13.

13. Chen AF, Wessel CB, Rao N. Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res. 2013;471:2383e2399.

14. Chen AF, Wessel CB, Rao N. Reply to the letter to the editor: Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res. 2013;471:3712e3713.

15. Rao N, Cannella BA, Crossett LS, Yates AJ, McGough R, Hamilton CW. Preoperative screening/decolonization for Staphylococcus aureus to prevent orthopedic surgical site infection. Prospective cohort study with 2-year follow-up. J Arthroplasty. 2011;26:1501e1507.

16. Moroski NM, Woolwine S, Scharzkopf R. Is preoperative staphylococcal decolonization efficient in total joint arthroplasty. J Arthroplasty. 2015;30: 444e446.

17. Sporer SM, Rogers T, Abella L. Methicillin-resistant and methicillin-sensitive Staphylococcus aureus screening and decolonization to reduce surgical site infection in elective total joint arthroplasty. J Arthroplasty. 2016;31:144e147.

18. Parvizi J, Shohat N, Gehrke T. Prevention of periprosthetic joint infection. Bone Joint J. 2017;99:3e10.

19. Jain R, Kralovic SM, Evans ME. Veterans Affairs initiative to prevent methicillinresistant Staphyloccocus aureus infections. N Engl J Med. 2011;364:1419e1430.

20. Dancer SJ, Christison F, Eslami A, et al. Is it worth screening elective orthopaedic patients for carriage of Staphyloccocus aureus? A part-retrospective case-control study in a Scottish hospital. BMJ Open. 2016;6:011642.

21. Anderson MJ, David ML, Scholz M, et al. Efficacy of skin and nasal povidoneiodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares. Antimicrob Agents Chemother. 2015;59:2765e2773.

22. Kline S, Highness M, Herwaldt LA, Perl TM. Variable screening and decolonization protocols for Staphylococcus aureus carriage prior to surgical procedures. Infect Control Hosp Epidemiol. 2014;35:880e882.

23. Diekema D, Johansson B, Herwaldt L, et al. Current practice in Staphylococcus aureus screening and decolonization. Infect Control Hosp Epidemiol. 2011;32: 1042e1044.

24. Parvizi J, Tan T, Goswami K, et al. The 2018 Definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty. 2018;33:1309e1314.

25. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall GC, ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2004:1659e1702.

26. Economedes DM, Deirmengian GK, Deirmengian CA. Staphylococcus aureus colonization among arthroplasty patients previously treated by a decolonization protocol: a pilot study. Clin Orthop Relat Res. 2013;471:3128e3132.

27. Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res. 2008;466:1349e1355.

28. Sankar B, Hopgood P, Bell KM. The role of MRSA screening in joint-replacement surgery. Int Orthop. 2005;29:160e163.

29. Paule SM, Pasquariello AC, Hacek DM, et al. Direct detection of Staphylococcus aureus from adult and neonate nasal swab specimens using real-time polymerase chain reaction. J Mol Diag. 2004;6:191e196.

30. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751e762.

31. Nixon M, Jackson B, Varghese P, Taylor G. Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br. 2006;88:812e817.

32. Wilcox MH, Hall J, Pike H, et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect. 2003;54:196e201.

33. Baratz MD, Hallmark R, Odum SM, Springer BD. Twenty percent of patients remain colonized with methicilin-resistant Staphylococcus aureus despite a decolonization protocol in patients undergoing elective total joint arthroplasty. Clin Orthop Relat Res. 2015;473:2283e2290.

34. Perl Trish M, Cullen Joseph J, Wenzel Richard P, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871e1877.

35. Phillips M, Rosenberg A, Shopsin B, et al. Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidoneiodine solution. Infect Control Hosp Epidemiol. 2014;35:826e832.

36. Verhoeven PO, Berthelot P, Chapelle C, et al. Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Letter to the editor. Clin Orthop Relat Res. 2013;471:3709e3711.

37. WHO Global guidelines on the prevention of surgical site infection. http:// www.who.int/gpsc/ssi-prevention-guidelines/en.

38. Barnes S. An enhanced benchmark for prosthetic joint replacement infection rates. Am J Infect Control. 2006;34:669e670.

39. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant S. aureus carriage: a systematic review. Clin Infect Dis. 2009;48:922e930.

40. Barbero Allende JM, Romanyk Cabrera J, Montero Ruiz E, et al. Eradication of Staphylococcus aureus in carrier patients undergoing joint arthroplasty. Enferm Infecc Microbiol Clin. 2015;33:95e100.